October 30, 2014, New York, NY - The New York Blood Center's Milstein National Cord Blood Program is pleased to announce that HEMACORDA , the first FDA-licensed hematopoietic stem cell product, has been awarded the prestigious "Best Biotechnology Product" Award by Prix Galien USA. The award recognizes "biomedical products that advance the human condition and which were approved by the U.S. Food and Drug Administration during the past five years," according to the Galien Foundation.
http://ift.tt/1tn8Eqx
http://ift.tt/1tn8Eqx
No comments:
Post a Comment